Furthermore, the strong correlation between the SUVmax and Gleason scores observed in this study supports the utility of metabolic imaging in assessing tumor aggressiveness, as also highlighted by Masselli et al. in their investigation of [68Ga]Ga-PSMA PET/CT’s role in advanced prostate cancer staging [21]. This evidence concerns the gene FOLH1 and Familial prostate cancer.